Antibacterial Mechanisms and Clinical Impact of Sitafloxacin
Sitafloxacin is a 4th generation fluoroquinolone antibiotic with broad activity against a wide range of Gram-negative and Gram-positive bacteria. It is approved in Japan and used to treat pneumonia and urinary tract infections (UTIs) as well as other upper and lower respiratory infections, genitouri...
Bewaard in:
| Hoofdauteurs: | , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI AG
2024-11-01
|
| Reeks: | Pharmaceuticals |
| Onderwerpen: | |
| Online toegang: | https://www.mdpi.com/1424-8247/17/11/1537 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|